🇺🇸 FDA

Company profile · Sponsor

Zambon

Zambon SpA

E65D76E · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Zambon (E65D76E) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E65D76E
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. H006629, H006629, H006629, LEVODOPA AND DECARBOXYLASE INHIBITOR , H006629

    Zambon

    Motor fluctuations in advanced Parkinson’s disease

    phase 3 small molecule active

    1 trial

  2. Liposomal Ciclosporin A, Liposomal Ciclosporin A

    Zambon

    Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Zambon?

Zambon (E65D76E) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Zambon sponsor?

We track 2 ClinicalTrials.gov-linked programs for Zambon, including H006629, H006629, H006629, LEVODOPA AND DECARBOXYLASE INHIBITOR , H006629 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Zambon company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.